Safety and efficacy of leriglitazone for preventing disease progression in men with adrenomyeloneuropathy (ADVANCE): a randomised, double-blind, multi-centre, placebo-controlled phase 2–3 trial

Wolfgang Köhler, Marc Engelen, Florian Eichler, Robin Lachmann, Ali Fatemi, Jacinda B. Sampson, Ettore Salsano, Josep Gámez, Mária Judit Molnár, Sílvia Pascual, M Rovira, A. Vilà, Guillem Pina, Itziar Martín-Ugarte, Adriana Mantilla, Pilar Pizcueta, Laura Rodríguez‐Pascau, Estefania Traver, Anna Vilalta, M. Pascual, Marc Martinell, Uwe Meya, Fanny Mochel, Eavan M. Mc Govern, Elise Yazbeck, Magali Barbier, Marie‐Pierre Luton, Françoise Pousset, Jean‐Yves Hogrel, Isaac Adanyeguh, Florian Then Bergh, Caroline G. Bergner, Astrid Unterlauft, Hannes Roicke, Karl‐Titus Hoffmann, Cordula Scherlach, Andrea Kalb, Bianca Meilick, Mandy Reuschel, Silvia Fenu, Elena Mauro, Elaine Murphy, Gauri Krishna, Tiggy Beyene, Alba Sierra, Sara Quiñoa, Anna Belen Canovas, Zoltán Grosz, Báthori Györgyi, S.I. van de Stadt, Irene C. Huffnagel, Wouter J. C. van Ballegoij, Marije M C Voermans, Reza Sadjadi, Camille Corre, Neha Godbole, Natalie Grant, Claudia Maria Brito Pires, Melissa Trovato, Nancy Yeh, Jordan Goodman, Jennifer Keller, Chris Joseph, Keith Van Haren, Sarada Sakamuri, Tina Duong, Lila Perrone, Stephanie Tran, Sally Dunaway Young, Syed Hashmi